Articles with the keyword: 
Consent issues restrict stem-cell use and research
sea-maid submitted, created time 5 months 1 week (www.nature.com)
Some researchers in Stanford University are told that around one-quarter of the human embryonic stem-cell lines eligible for U.S. government funding are now off-limits because of ethical concerns. The university is concerned that some of the women who donated the embyros that were used to generate the line might not have been fully informed of how they would be used.
The consent forms that the women signed were retrieved and it was found that none of them met Standford's guidelines exactly and some of them were way off the mark 


Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Siegfried submitted, created time 1 year 3 months (bloodjournal.hematologylibrary.org)
Allogeneic hematopoietic stem-cell transplantation (HSCT) is the only curative treatment for sickle cell disease (SCD); nevertheless, its use has been limited by the risk of transplantation-related mortality (TRM).Between November 1988 and December 2004, 87 consecutive patients with severe SCD ranging from 2 to 22 years of age received transplants in France. 
\ 1
\